RBI
AXSM icon

Raiffeisen Bank International’s Axsome Therapeutics AXSM Stock Holding History

Raiffeisen Bank International’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$147K Hold
600
– – ﹤0.01% 534
2026
Q1 		$101K Hold
600
– – ﹤0.01% 527
2025
Q4 		$75.1K Hold
600
– – ﹤0.01% 523
2025
Q3 		$72.9K Buy
+600
New +$67.6K ﹤0.01% 530

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

Raiffeisen Bank International's AXSM Position: Q3 2025 in Review

Raiffeisen Bank International sold out of Axsome Therapeutics (AXSM) in Q3 2025, closing a stake of 600 shares — an estimated $67.6K sold.

Raiffeisen Bank International first reported a position in AXSM in Q4 2024 and held it in 3 quarters. The position peaked at $70K in Q1 2025. 355 funds tracked by Wall St. Rank hold AXSM as of Q3 2025.

  • Raiffeisen Bank International reported no remaining Axsome Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Raiffeisen Bank International sold 600 Axsome Therapeutics shares in Q3 2025, an estimated $67.6K.
  • Raiffeisen Bank International first reported a position in Axsome Therapeutics in Q4 2024 and held it in 3 quarters.
  • Raiffeisen Bank International's Axsome Therapeutics position peaked at $70K in Q1 2025.
  • 355 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2025.

Based on Raiffeisen Bank International's 13F filing for Q3 2025, filed 10 Nov 2025.